Search This Blog

Tuesday, October 4, 2022

Takeda Pharmaceutical to Discontinue Manufacturing of Natpar/Natpara by End of 2024

 Hypothyroidism treatment

https://www.marketscreener.com/quote/stock/TAKEDA-PHARMACEUTICAL-COM-6491073/news/Takeda-Pharmaceutical-to-Discontinue-Manufacturing-of-Natpar-Natpara-by-End-of-2024-41922382/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.